BROSSARD, Quebec, Sept. 20, 2024 (GLOBE NEWSWIRE) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technolo
Additional information is available at www.diagnos.ca and www.sedarplus.com. Read More